principal investigator for dt trial, page-5

I really don't think this stock will be included in the tax loss selling.
The fact is most investors TFY have bought in at the low price or below the price it is now.
Personally i'm in front (just) but have been accumulating TFY waiting for the reversal as i think there will be good money to be made when the news starts flowing.
Biotechs IMO will come into there own next financial year as investors chase the next sector to move.
Theres just too much liquidity in the markets at the moment and will be for some time.
No doubt this will be a success story and i think the insto's will soon take positions.